Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
November 17, 2025
Pharmaceuticals
-
-
Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG
October 23, 2025
-
Shuttle Executes LOI with Molecule.ai
October 10, 2025
-
cbdMD’s Herbal Oasis Expands its Florida Footprint with Bevtalk Distribution Partnership
October 9, 2025
-
Safety Shot, Inc. to Become Bonk, Inc., to Trade on Nasdaq Under New Ticker Symbol “BNKK”
October 9, 2025
-
Safety Shot Acquires 2.7% of BONK’s Circulating Supply, Sets Year-End Target of 5%
October 8, 2025
-
Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
September 25, 2025
-
22nd Century Secures $9.5 Million Cash Proceeds from Settlement of Insurance Claim
September 24, 2025
-
Biofrontera Inc. Engages Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program
September 23, 2025
-
Safety Shot Secures $30 Million Strategic Investment From BONK Core Team and FalconX
August 25, 2025
-
Apollo Biowellness, Inc., Corporate Update
August 18, 2025
-
Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy
August 6, 2025
-
Safety Shot Completes Acquisition of Yerbae Brands Corp.
June 27, 2025
-
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
May 21, 2025
-
Red Light Holland’s FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company’s Raw Psilocybin Truffles
May 21, 2025
-
TerrAscend Signs Agreement to Acquire Fourth Dispensary in New Jersey
May 6, 2025